Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor) Fab Fragment (Human-Mouse Monoclonal Rhufab V2 1-Chain), Disulfide With Human-Mouse Monoclonal Rhufab V2 Light Chain
Malignant Choroid Melanoma
New England Retina Associatesmonoclonal_antibodyPhase 3Dormant
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Malignant Choroid Melanoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Belzupacap Sarotalocan Aura Biosciences | Phase 2 | BB |
Bel-Sar Aura Biosciences | Phase 3 | B |
Ibuprofen Royal Liverpool University Hospital | Phase 1/2 | CCC |
(±)-Tramadol Royal Liverpool University Hospital | Phase 1/2 | CCC |
Tyrosinase-Related Protein-1 Mayo Clinic | Phase 1 | CC |
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta Mayo Clinic | Phase 1 | CC |
Same molecule, other indications
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor) Fab Fragment (Human-Mouse Monoclonal Rhufab V2 1-Chain), Disulfide With Human-Mouse Monoclonal Rhufab V2 Light Chain is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →